RAF1 S257L/S259F hotspot mutations: functional characterization and intrinsic resistance to the RAS(ON) inhibitor daraxonrasib in melanoma.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.